CIK 0001285819 · Non-accelerated filer<br>Smaller reporting company
OMEROS CORP
Sign in to watch- Ticker
- OMER
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- WA
- Entity type
- operating
- EIN
- 911663741
- Phone
- 206-676-5000
- Business address
- 201 ELLIOTT AVENUE WEST, SEATTLE, WA, 98119
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,114,339
- in 5 filings, $626K under 10b5-1 plans
Net −$2,114,339. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-05-22 | HANISH ARNOLD C Director | Option exercise · Stock Option (Right to Buy) | −5,000 | 0 | ||
| 2023-05-22 | Cable Thomas J. Director | Option exercise | +5,000 | $5.30 | $27K | 40,067 |
| 2023-05-22 | Cable Thomas J. Director | Sale | −5,000 | $6.53 | $33K | 35,067 |
| 2023-05-22 | Cable Thomas J. Director | Option exercise · Stock Option (Right to Buy) | −5,000 | 0 | ||
| 2023-05-12 | Perkinson Diana T. Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2022-09-21 | Cable Thomas J. Director | Grant or award · Stock Option (Right to Buy) | +7,500 | 7,500 | ||
| 2022-09-21 | Bumol Thomas F. Director | Grant or award · Stock Option (Right to Buy) | +7,500 | 7,500 | ||
| 2022-09-21 | Shah Rajiv Director | Grant or award · Stock Option (Right to Buy) | +7,500 | 7,500 | ||
| 2022-09-21 | Demopulos Peter A MD Director | Grant or award · Stock Option (Right to Buy) | +7,500 | 7,500 | ||
| 2022-09-21 | Hood Leroy E. MD PhD Director | Grant or award · Stock Option (Right to Buy) | +7,500 | 7,500 | ||
| 2022-09-21 | Zumwalt Kurt Director | Grant or award · Stock Option (Right to Buy) | +7,500 | 7,500 | ||
| 2022-09-21 | HANISH ARNOLD C Director | Grant or award · Stock Option (Right to Buy) | +7,500 | 7,500 | ||
| 2022-09-21 | Demopulos Gregory A MD CHAIRMAN, CEO & PRESIDENT | Grant or award · Stock Option (right to buy) | +650,000 | 650,000 | ||
| 2022-09-21 | JACOBSEN MICHAEL A VP FINANCE AND CAO | Grant or award · Stock Option (right to buy) | +85,000 | 85,000 | ||
| 2022-09-21 | Cancelmo Peter B VP, GENERAL COUNSEL | Grant or award · Stock Option (right to buy) | +80,000 | 80,000 | ||
| 2022-06-17 | Zumwalt Kurt Director | Grant or award · Stock Option (Right to Buy) | +7,500 | 7,500 | ||
| 2022-06-17 | Shah Rajiv Director | Grant or award · Stock Option (Right to Buy) | +7,500 | 7,500 | ||
| 2022-06-17 | Demopulos Peter A MD Director | Grant or award · Stock Option (Right to Buy) | +7,500 | 7,500 | ||
| 2022-06-17 | Hood Leroy E. MD PhD Director | Grant or award · Stock Option (Right to Buy) | +7,500 | 7,500 | ||
| 2022-06-17 | HANISH ARNOLD C Director | Grant or award · Stock Option (Right to Buy) | +7,500 | 7,500 |
Page 6 of 9 · 178 trades